, /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global Glaucoma Therapeutics Market is experiencing significant growth owing to the surging incidence of glaucoma. The report runs an in-depth analysis of market trends, key players, and future opportunities. The glaucoma therapeutics market is analyzed on the basis of drug type, indication, and distribution channel.
The report from The Insight Partners provides several stakeholders—including manufacturers, physicians and other end users—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
Download Sample Pages of Research analysis: https://www.theinsightpartners.com/sample/TIPRE00018828/
Overview of Report Findings
- Market Growth: The global glaucoma therapeutics market is expected to reach a value of US$ 8,020.0 million by 2031 from US$ 6,240.0 millionin 2023; it is expected to record a CAGR of 3.20% during the forecast period. Glaucoma is a chronic and progressive condition of the eyes, usually caused by damage to the optic nerve, resulting in loss of visual field. An …